Pages tagged "AB 849"

Research and experience show that sensible regulations are good for patients, providers, and communities

CA Capitol BuildingThe California State Legislature will return from summer recess on Monday, and three medical cannabis bills will be on the table that day. The Senate Appropriations committee will hear testimony on bills to license and regulate commercial medical cannabis activity and to toughen laws related to manufacturing concentrated cannabis. You can read more about AB 243 (Wood), AB 266 (Bonta), and AB 849 (Bonilla) on ASA’s email discussion list or our website.

While California has been slow to license and regulate commercial medical cannabis activity, other states have already moved successfully in that direction. Patients in Colorado, Arizona and Maine already get their medicine from fully functional and well-regulated medical cannabis programs.  ASA is committed to bringing the proven benefits of regulation to patients and other stakeholders in California. 

Read more